UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001980
Receipt number R000002416
Scientific Title Randomized Controlled trial to evaluate the effectiveness of total colonoscopy in colorectal cancer screening
Date of disclosure of the study information 2009/05/18
Last modified on 2020/08/04 18:13:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized Controlled trial to evaluate the effectiveness of total colonoscopy in colorectal cancer screening

Acronym

Randomized Controlled trial to evaluate the effectiveness of total colonoscopy in colorectal cancer screening

Scientific Title

Randomized Controlled trial to evaluate the effectiveness of total colonoscopy in colorectal cancer screening

Scientific Title:Acronym

Randomized Controlled trial to evaluate the effectiveness of total colonoscopy in colorectal cancer screening

Region

Japan


Condition

Condition

Colorectal Cancer

Classification by specialty

Gastroenterology Laboratory medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To verify effectiveness of total colonoscopy compared to fecal occult blood test in colorectal cancer screening

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Mortality rate of colorectal cancer

Key secondary outcomes

Sensitivity and specificity of colorectal cancer, cumulative incidence rate of advanced colorectal cancer, and cumulative incidence rate of invasive colorectal cancer


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Fecal occult blood test added to total colonoscopy

Interventions/Control_2

Fecal occult blood test

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

74 years-old >=

Gender

Male and Female

Key inclusion criteria

1.40 years to 74 years when registered
2.Signed the informed consent to participate in the study

Key exclusion criteria

1.History of colorectal cancer
2.Familial adenomatous polyposis, family history of hereditary non-polyposis colorectal cancer and inflammatory bowel disease (ulcerative colitis and crohn' s disease)
3.Malignant disease other colorectal cancer within 5 years
4.In severe condition, who are expected to live for 5 years

Target sample size

10000


Research contact person

Name of lead principal investigator

1st name Shin-ei
Middle name
Last name Kudo

Organization

Showa University Northern Yokohama Hospital

Division name

Digestive Disease Center

Zip code

224-8503

Address

35-1 Chuo Chigasaki Tsuzuki-ku Yokohama-city Kanagawa Japan

TEL

045-945-0686

Email

kudos@med.showa-u.ac.jp


Public contact

Name of contact person

1st name Takahisa
Middle name
Last name Matsuda

Organization

National Cancer Center Hospital

Division name

Research Center for Cancer Prevention and Screening

Zip code

104-0045

Address

5-1-1 Tsukiji Chuo-ku Tokyo Japan

TEL

03-3542-2511

Homepage URL


Email

tamatsud@ncc.go.jp


Sponsor or person

Institute

Digestive Disease Center, Showa University Northern Yokohama Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

National Cancer Center

Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Cancer Center Ethics Review Committee

Address

5-1-1 Tsukiji Chuo-ku Tokyo Japan

Tel

03-3542-2511

Email

NCC_IRBoffice@ml.res.ncc.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

仙北市健康管理センター
大仙市健康増進センター
仙北市立角館総合病院
秋田赤十字病院


Other administrative information

Date of disclosure of the study information

2009 Year 05 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2009 Year 04 Month 20 Day

Date of IRB

2009 Year 04 Month 03 Day

Anticipated trial start date

2009 Year 06 Month 01 Day

Last follow-up date

2026 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 05 Month 18 Day

Last modified on

2020 Year 08 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002416


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name